Showing results (1431-1440 of 1,555) with videos related to
Sort By:
Pageof 156
Contemporary Clinical Trials Communications|May 9, 2018
Attitudes and motivations regarding willingness to participate in dental clinical trialsLynn Roosa Friesen, Karen B WilliamsContemporary Clinical Trials Communications|May 9, 2018
Factors affecting patient participation in clinical trials in Ireland: A narrative reviewElaine Walsh, Ann SheridanContemporary Clinical Trials Communications|May 9, 2018
Genomic and clinical predictors for improving estimator precision in randomized trials of breast cancer treatmentsPrasad Patil, Elizabeth Colantuoni, Jeffrey T Leek, et al.Contemporary Clinical Trials Communications|May 9, 2018
Effects of intensive induction and consolidation chemotherapy with idarubicin and high dose cytarabine on minimal residual disease levels in newly diagnosed adult precursor-B acute lymphoblastic leukemiaKenneth F Bradstock, Alec Morley, Karen Byth, et al.Contemporary Clinical Trials Communications|May 9, 2018
A randomized placebo-controlled trial of the effect of coffee consumption on insulin sensitivity: Design and baseline characteristics of the Coffee for METabolic Health (COMETH) studyDerrick Johnston Alperet, Salome Antonette Rebello, Eric Yin-Hao Khoo, et al.Contemporary Clinical Trials Communications|May 9, 2018
Development of an open prospective observational multicentre cohort study to determine the impact of standardization of laparoscopic intraperitoneal onlay mesh repair (IPOM) for incisional hernia on clinical outcome and quality of life (LIPOM-Trial)A Hellinger, F Wotzlaw, V Fackeldey, et al.Contemporary Clinical Trials Communications|May 9, 2018
A novel standard to evaluate the impact of therapeutic agents on patient safety - The BURDEN OF THERAPY™©∗Ayad K Abdulahad, Robert J Snijder, Moeen K Panni, et al.Contemporary Clinical Trials Communications|April 17, 2019
Cohort profile of the PRoteomic Evaluation and Discovery in an IBD Cohort of Tri-service Subjects (PREDICTS) study: Rationale, organization, design, and baseline characteristicsChad K Porter, Mark S Riddle, Ramiro L Gutierrez, et al.Contemporary Clinical Trials Communications|June 14, 2019
Evaluating the effects of design parameters on the performances of phase I trial designsYaqian Zhu, Wei-Ting Hwang, Yimei LiContemporary Clinical Trials Communications|June 14, 2019
Antidepressant discontinuation in treatment resistant depressionZiad A Ali, Sharon Nuss, Rif S El-MallakhPageof 156